Novavax, Inc.

NASDAQ:NVAX  
18.22
-0.35 (-1.88%)
4:02:51 PM EDT: $18.22 0.00 (0.00%)
Products

Novavax And Serum Institute Of India Announce Full Product Registration In South Africa Of Novavax Covid-19 Vaccine

Published: 09/13/2022 12:29 GMT
Novavax, Inc. (NVAX) - Novavax and Serum Institute of India Announce Full Product Registration in South Africa of Novavax Covid-19 Vaccine As a Primary Series for Adults Aged 18 and Older.
Novavax Inc - in Both Trials, Vaccine Demonstrated Efficacy With a Reassuring Safety and Tolerability Profile.
Novavax Inc - Serious and Severe Adverse Events Were Low in Number and Balanced Between Vaccine and Placebo Groups.